By: 12 August 2020
MT Ortho harnesses additive technology to manufacture customised prostheses for cranioplasty and bone cancer patients

Until just a few years ago only standardised, conventionally manufactured prostheses – or in very limited cases customised prostheses – were available for patients with bone tumours.

Today, a combination of additive manufacturing and CT imaging is making it possible to create truly customised prostheses. At the cutting edge of this technology is MT Ortho, based on the Italian island of Sicily.

Building on two-decades’ experience in the Italian clinical-hospital market for standardised prostheses, MT Ortho started to embrace additive manufacturing in 2014. That year also marked a series of arrivals at the company; a recent graduate engineer, Simone Di Bella, who had specialised in additive manufacturing and two GE Additive Arcam Electron Beam Melting (EBM) machines.

“Our goal was to become not only a distributor, but also a manufacturer of medical devices. And our vision was to achieve this by creating new, innovative devices with unique features that were only possible by using additive manufacturing and were more compatible with the human bone than metals on the market at the time,” explains Di Bella.

The team at MT Ortho initially focused on the production of customised prostheses, for neurosurgical applications (custom cranioplasty) and oncological orthopaedics (mega-prostheses reconstruction). At the same time, the company launched several projects to obtain the European CE mark for several devices in the field of neurosurgery.

One of these projects includes ground-breaking work to develop an innovative kyphoplasty implant for the treatment of vertebral collapse. This device will make it possible to replace current bone fillers, such as cements and bio-cements, with an osteoinductive material eliminating all possible negative effects related to the current technology in use.

Combining diagnostic imaging technologies with the design freedom of additive manufacturing has opened up new opportunities in prosthetics, enabling customised patient devices and improving the effectiveness of diagnosis, planning, surgery and clinical outcomes.

Customised prostheses are medical devices exclusively designed for an individual patient, in order to adapt to their particular pathology, and then manufactured according to their specific diagnostic images.

This type of implant is mainly used when bone geometry is not within the dimensional range of standard implants, when there are special requirements due to disease, or simply when a tailor-made solution enables a better clinical result.

For the successful use of the customised prostheses the interprofessional cooperation and communication between the orthopaedic surgeon and the implant designer is key.

The implant designer may not be familiar with anatomopathological, epidemiological, surgical or resection/reconstruction procedures. While, the orthopaedic surgeon may not have an in-depth understanding of the process of producing a physical additively manufactured model.

Leveraging its experience distributing a wide range of medical-surgical devices to hospitals, public and private healthcare facilities and now with additive technologies, MT Ortho has continued to develop innovative solutions for orthopaedic surgery, oncological orthopaedics, neurosurgery and maxillofacial surgery – all sectors whose needs often cannot be met by conventional manufacturing methods.

This has led, to the development of a new line of customised cranioplasty prostheses, now in use throughout Europe. The use of additive technology in cranioplasty makes the prosthetics process easier and much more precise. In addition, the characteristics of the technology make it possible to achieve an optimal structure for osseointegration.

And by virtue of the speed and precision of the technology it is also much easier today to carry out the so-called demolition/reconstruction operations of cranioplasty in a single step.

These interventions are based on a completely different surgical strategy, that allows the most precise planning of the intervention, for which MT Ortho provides not only the prosthesis but also the cutting templates – following the precise mapping of the intervention area by a CT scan.

In surgery, the removal of the area affected by disease, and the insertion of the cranial prosthesis, can take place simultaneously, drastically reducing the post-operative hospitalization and recovery time and the risk of infection. This is particularly important for interventions in sensitive areas such as the ocular orbit or the cranio-maxillofacial region.

To develop customised prostheses, it is necessary to go through a series of steps.

 

From the outset, this process requires close cooperation between the surgeon responsible for the procedure and MT Ortho’s engineering team.

  • The first step is a CT scan, in order to make it possible to build a 3D model of the specific anatomical characteristics of the patient.
  • A conference call is then held with the doctor, where the intervention is discussed, and access routes identified.
  • Designers then determine the characteristics of the fixing systems, considering the resistance of the material.
  • The prosthesis is designed, and then reviewed with the surgeon, for all aspects of feasibility.
  • Finally, the prosthesis is printed, often with a backup copy, to support any unexpected events or problems. The prosthesis usually does not require any special post-treatment other than washing and final sterilisation, which can take place at the source or in an autoclave at the destination hospital.
  • MT Ortho product specialists are sometimes present in the operating room during surgery and assist the surgeon with proper positioning.

Bone cancer is one application area where additive manufacturing can offer advantages, especially when combined with digital image processing and artificial intelligence technologies, making it possible to prepare a 3D intervention plan through the fusion of several CT images.

The full design freedom offered by additive technology allows for the manufacture of customised prostheses that consider deformation and the need to adequately distribute loads.

One specialist area of expertise developed by MT Ortho is cancer prosthetics, for bone sarcomas or chondrosarcomas.

Using additive technologies, it is possible to perfectly reconstruct the bone anatomy of patients after demolition surgery performed for the removal of a tumor.

This area of expertise has been particularly successful thanks to a collaboration with the Department of Oncological Orthopaedics at the National Cancer Institute Regina Elena of Rome (IRE) in Rome, where MT Ortho is achieving encouraging intervention results. This collaboration is leading the company to expand its services further to include surgical aids, such as cutting guides and precision positioning of prostheses.

Another aspect that will drive the further growth of customised prostheses is cost. A study conducted in New Zealand[1] compared the overall costs in the case of hip arthroplasty between standardised and customised prostheses.

Considering the shorter hospitalisation times, and more effective results, the study showed an overall cost saving of 13% when customised prostheses were used in the field of oncology.

Since the study assumed an average post-operative stay of four to five days in the case of customised prostheses, compared to an average of seven to 10 days in the case of standardised prostheses, not to mention the need to have a large stock of sizes and materials.

And given that hospitalisation is one of the major cost burdens in the healthcare system, if the time savings for theatre and operating personnel are added, the final budget is decisively favourable to customised prostheses.

 Reference:

[1] An Early Stage Assessment of Cost Savings from the use of Ossis Custom Trabecular Acetabular Revision Components in the Treatment of Severe Acetabular Defects – D. Body, BE. MBA., M. Martin, B.Com. BE. MEngSt., J. Hands, LLB. BCom, Ossis Limited, Christchurch, New Zealand